Treatment of Mycobacterium Infections
Treatment of mycobacterial infections requires multiple antimicrobial agents for extended periods, with regimens tailored to the specific mycobacterial species and site of infection. 1
Types of Mycobacterial Infections
Tuberculosis (M. tuberculosis)
- First-line treatment includes:
- Treatment duration: Typically 6-9 months
- The fourth drug (ethambutol or streptomycin) should be included unless the likelihood of drug resistance is very low 2
- Reassess need for fourth drug when susceptibility results are available
Non-Tuberculous Mycobacteria (NTM)
M. avium Complex (MAC)
- Treatment regimen:
- Treatment duration: At least 12 months after culture conversion 1
- For HIV patients with disseminated MAC:
M. kansasii
- Treatment regimen:
- Rifampin (600 mg daily)
- Ethambutol (15 mg/kg daily)
- Isoniazid (300 mg daily) 1
- Treatment duration: 12 months after culture conversion 1
M. malmoense and M. xenopi
- Treatment regimen:
- Rifampin (450-600 mg daily)
- Ethambutol (15 mg/kg daily)
- Clarithromycin (500 mg twice daily) 1
- Treatment duration: 24 months 1
Rapidly Growing Mycobacteria (M. chelonae, M. fortuitum, M. abscessus)
- Treatment regimen:
- Treatment duration:
- Surgical debridement is essential when possible 5
- Complete removal of infected foreign bodies is crucial 5
M. marinum (Fish Tank Granuloma)
- Treatment options:
- Cotrimoxazole, or
- Tetracycline, or
- Rifampin plus ethambutol 1
- Treatment duration: 6 months 1
M. ulcerans
- Wide surgical excision with skin grafting is the treatment of choice 1
- Early disease may respond to rifampin, ethambutol, and clarithromycin 1
Monitoring Treatment
Clinical monitoring:
Microbiological monitoring:
Response timeline:
Important Considerations
- Multiple isolates from non-sterile sites are needed to establish disease, whereas one positive culture from a sterile site with supportive histopathology is usually sufficient 1
- Person-to-person transmission of NTM is very rare; contact tracing is not necessary 1
- If a patient has been notified as having tuberculosis but is later found to have NTM, they should be de-notified and treatment adjusted accordingly 1
- Susceptibility testing should guide therapy, especially for rapidly growing mycobacteria 1, 5
- Cure may not be attainable in some cases, particularly with pulmonary disease caused by rapidly growing mycobacteria 1
Common Pitfalls to Avoid
- Inadequate treatment duration
- Monotherapy (always use at least two effective agents)
- Failure to remove foreign bodies when present
- Overlooking surgical intervention when indicated
- Not adjusting therapy based on susceptibility results
- Failing to recognize when NTM represents colonization versus true infection